Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on July 25, 2005

Circulation. 2005
Published online before print July 25, 2005, doi: 10.1161/CIRCULATIONAHA.104.515072
A more recent version of this article appeared on August 2, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
112/5/658    most recent
CIRCULATIONAHA.104.515072v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gu, D.
Right arrow Articles by He, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gu, D.
Right arrow Articles by He, J.
Related Collections
Right arrow Epidemiology
Right arrow Risk Factors

Submitted on October 18, 2004
Revised on April 9, 2005
Accepted on April 12, 2005

Prevalence of Cardiovascular Disease Risk Factor Clustering Among the Adult Population of China. Results From the International Collaborative Study of Cardiovascular Disease in Asia (InterAsia)

Dongfeng Gu MD, MSc, Anjali Gupta MPH, Paul Muntner PhD, MHS*, Shengshou Hu MD, Xiufang Duan MD, Jichun Chen MS, Robert F. Reynolds ScD, Paul K. Whelton MD, MSc, and Jiang He MD, PhD

From the Cardiovascular Institute and Fu Wai Hospital (D.G., S.H., X.D., J.C.), Chinese Academy of Medical Sciences and Peking Union Medial College, Beijing, China; the Department of Epidemiology (A.G., P.M., P.K.W., J.H.), Tulane University School of Public Health and Tropical Medicine, and Department of Medicine (P.M., P.K.W., J.H.), Tulane University School of Medicine, New Orleans, La; and Global Epidemiology (R.F.R.), Pfizer Inc, New York, NY.

* To whom correspondence should be addressed. E-mail: pmuntner{at}tulane.edu.

Background--The prevalence of cardiovascular disease (CVD) risk factors has been increasing in China.

Methods and Results--We examined the prevalence of CVD risk factor clustering among Chinese adults aged 35 to 74 years with data from the International Collaborative Study of Cardiovascular Disease in Asia (InterAsia), a cross-sectional survey of a nationally representative sample (n=14 690) conducted during 2000 to 2001 and compared these data with those of US adults from the National Health and Nutrition Examination Survey of 1999 to 2000. Overall, 80.5%, 45.9%, and 17.2% of Chinese adults had ≥1, ≥2, and ≥3 modifiable CVD risk factors (dyslipidemia, hypertension, diabetes, cigarette smoking, and overweight), respectively. By comparison, 93.1%, 73.0%, and 35.9% of US adults had ≥1, ≥2, and ≥3 of these risk factors, respectively. In a multivariate model including age, sex, and area of residence, the odds ratio (95% confidence interval [CI]) of having ≥1, ≥2, and ≥3 CVD risk factors versus none of the studied risk factors was 2.61 (95% CI, 2.09 to 3.27), 3.55 (95% CI, 2.77 to 4.54), and 4.97 (95% CI, 3.67 to 6.74), respectively, for Chinese adults 65 to 74 years old versus 35 to 44 years old; 3.65 (95% CI, 3.21 to 4.15), 4.67 (95% CI, 4.06 to 5.38), and 5.60 (95% CI, 4.70 to 6.67), respectively, for men compared with women; 1.18 (95% CI, 1.07 to 1.30), 1.34 (95% CI, 1.21 to 1.50), and 1.84 (95% CI, 1.60 to 2.12), respectively, for urban compared with rural residents; and 1.98 (95% CI, 1.76 to 2.22), 2.75 (95% CI, 2.42 to 3.13), and 4.36 (95% CI, 3.68 to 5.18), respectively, for residents of northern compared with southern China.

Conclusions--Clustering of CVD risk factors is common in China. Prevention, detection, and treatment of CVD risk factor clustering should be an important component of a national strategy to reduce the increasing burden of CVD in China.


Key words: diabetes mellitus • risk factors • hypertension • lipids • obesity




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
L. Mosca, C. L. Banka, E. J. Benjamin, K. Berra, C. Bushnell, R. J. Dolor, T. G. Ganiats, A. S. Gomes, H. L. Gornik, C. Gracia, et al.
Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women: 2007 Update
J. Am. Coll. Cardiol., March 20, 2007; 49(11): 1230 - 1250.
[Full Text] [PDF]


Home page
CirculationHome page
L. Mosca, C. L. Banka, E. J. Benjamin, K. Berra, C. Bushnell, R. J. Dolor, T. G. Ganiats, A. S. Gomes, H. L. Gornik, C. Gracia, et al.
Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women: 2007 Update
Circulation, March 20, 2007; 115(11): 1481 - 1501.
[Full Text] [PDF]